期刊文献+

抗SSA表位特异性单链噬菌体抗体的可溶性表达及鉴定 被引量:2

The soluble expression and identification of single-chain fragment V antibodies against SSA antigen epitopes from the pHEN2 phagemid library
原文传递
导出
摘要 目的 获得可溶性抗人SSA抗原表位特异性单链抗体(ScFv).方法 以赖氨酸为支架八倍体合成3条相对分子质量为60 000的SSA抗原氨基酸多肽链(MAP):MAP 482~493(P1表位)、MAP 310~323(P2表位)和MAP 230~241(P3表位).以P1~P3表位为包被抗原,富集筛选相应的噬菌体单克隆抗体(McAb);阳性克隆特异性、亲和力和序列分析鉴定;表位特异性McAb可溶性表达和鉴定.结果 5轮筛选后,获得了抗3种表位抗体的含完整插入片断的克隆株,具有较高亲和力和特异性.抗P1~P3抗体融合蛋白与相应表位反应的410 nm吸光度值分别为1.43±0.23、0.82±0.31、0.80±0.25,组间交叉反应差异有统计学意义(P值均小于0.01).其中3个克隆表位特异性McAb-ScFv克隆成功,可溶性表达并纯化.以Hep-2细胞为底物,间接免疫荧光法(ⅡF)检测显示,可溶性ScFv抗体具有在体活性.结论 筛选获得的阳性克隆成功,可溶性表达并具有较好的亲和力、特异性和在体活性,可胜任靶器官的表位表达情况的检测. Objective To obtain the soluble single-chain fragment V (ScFv)monoclonal antibodies (McAbs) against the SSA antigen epitopes.Methods Three octapeptides (60 000 SSA antigen residues 482-493 termed as P1 epitope, residues 310-323 termed as P2 epitope and residues 230-241 termed as P3 epitope) were synthesized on the lysine frame.The McAbs were panned by coating the corresponding as targets.The specificity, affinity and gene squences of the positive clones were assessed.Soluble single-chain fragment V antibodies special for SSA antigen epitopes were expressed and then identificated.Results After 5 rounds of panning, reactive scFv clones contained full-length scFv antibodies coding regions were obtained,with sufficient affinity and specificity for respective antigen peptides.The absorbance values at 410 nm of the fusion protein of anti-P1-P3 activity with the corresponding peptides were 1.43 ± 0.23, 0.82 ±0.31 and 0.80 ± 0.25, and there was also statistically significant difference in the cross reactions ( P 〈 0.01 ).Three clones were successfully expressed and then purified by His-bind resin.The activity in vivo of soluble ScFv antibodies was identified to be positive by the indirect immune-fluorescence assay on Hep-2 cells.Conclusion Souble ScFv McAbs against corresponding SSA antigen peptides with high affinity,specificity and activity in vivo were obtained, which are to be competent enough for epitopes expression on the target organs.
出处 《中华内科杂志》 CAS CSCD 北大核心 2010年第7期614-617,共4页 Chinese Journal of Internal Medicine
基金 国家自然科学基金(30471618) 国家科技支撑计划(2008BAI59B03)
关键词 抗体 噬菌粒 表位 可溶性表达 Antibodies Phagemid Epitopes Soluble expression
  • 相关文献

参考文献11

  • 1Clancy RM,Alvarez D,Komissarova E,et al.Ro60-associated single-stranded RNA links inflammation with fetal cardiac fibrosis via ligation of TLRs:a novel pathway to autoimmune-associated heart block.J Immunol,2010,184:2148-2155.
  • 2Sisto M,Lisi S,Lofrumento DD,et al.Induction of TNF-alphaconverting enzyme-ectodomain shedding by pathogenic autoantibodies.Int Immunol,2009,21:1341-1349.
  • 3李娅杰,刘莉,张奉春.SSA抗原及其不同阳性表位的临床意义[J].中华内科杂志,2003,42(3):165-168. 被引量:11
  • 4Kurien BT,Newland J,Paczkowski C,et al.Association of neutropenia in systemic lupus erythematosus (SLE) with anti-Ro and binding of an immunologically cross-reactive neutrophil membrane antigen.Clin Exp Immunol,2000,120:209-217.
  • 5Scofield RH,Asfa S,Obeso D,et al.Immunization with short peptides from the 60-kDa Ro antigen recapitulates the serological and pathological findings as well as the salivary gland dysfunction of Sjogren's syndrome.J Immunol,2005,175:8409-8414.
  • 6Reed JH,Jackson MW,Gordon TP.B cell apotopes of the 60-kDa Ro/SSA and La/SSB autoantigens.J Autoimmun,2008,31:263-267.
  • 7周炜,张奉春,唐福林,董怡.抗SSA噬菌体抗体库的构建及鉴定[J].中华风湿病学杂志,2003,7(7):394-398. 被引量:5
  • 8Franceschini F,Cavazzana I.Anti-Ro/SSA and La/SSB antibodies.Autoimmunity,2005,38:55 -63.
  • 9Huang SC,Yu H,Scofield RH,et al.Human anti-Ro autoantibodies bind peptides accessible to the surface of the native Ro autoantigen.Scand J Immunol,1995,41:220-228.
  • 10Gaberc-Porekar V,Menart V.Perspectives of immobilized-metal affinity chromatography.J Biochem Biophys Methods,2001,49:335-360.

二级参考文献13

  • 1Harley JB, Scofield RH, Reichlin M. Anti-Ro in Sjoegren's syndrome and systemic lupus erythernatosus. Rheum Dis Clin North Am,1992,18: 337-358.
  • 2Hoogenboom FIR, Chames P. Natural and designer binding sites made by phage display technology, Immunol Today,2000,21:371-378.
  • 3Welsehof M, Temess P, Kolbinger F, et al. Amino acid sequence based PCR primers for amplification of rearranged human heavy and light chain immuroglobulin variable region genes. J Immunol Methods, 1995,179: 203-214.
  • 4Wilson DR, Finlay 1313. Phage display:applications, innovations and issues in phage and host biology. Can J Microbiol, 1998, 44: 313-329.
  • 5Winter G, Griffiths AD, Hawkins RE, et al. Making antibodies by phage display technology. Annu Rev Immunol, 1994,12:433-455.
  • 6Eggena M,Targan SR, Iwanczyk L, et al. Phage display cloning and characterization of an immunogenetic marker (perinuclear anti-neutrophil cytoplasmic antibody) in ulcerative colitis. J Immunol, 1996,156:4005-4011.
  • 7Welschof M,Temess P, Kipriyanov SM, et al. The antigen-binding domain of a human IgG-anti-F(ab') 2 autoantibody. Proc Natl Acad Sci USA, 1997,94 : 1902-1907.
  • 8Seal SN,Hoet RA, Raats JM, et al. Analysis of autoimmune bone marrow by antibody-phage display. Arthritis Rheum, 2000, 43:2132-2138.
  • 9Chukwuocha RU, Hsiao ET,Shaw P,et al. Isolation,charaterization and sequence analysis of five IgG monoclonal anti-β2-glycoprotein-1 and anti-prothrombin antigen-binding fragments generated by phage display. J Immunol, 1999,163:4604-4611.
  • 10Hoet RM, Pieffers M, Stassen MH, et al. The importance of the light chain for the epitope specificity of htanan anti-U1 small nuclear RNA autoantibodies present in systemic lupus erythematosus patients. J Immunol, 1999,163:3304-3312.

共引文献11

同被引文献32

  • 1黄清水,万腊根,罗忠勤,乐爱平,王文强.抗环瓜氨酸肽抗体对类风湿关节炎诊断价值的荟萃分析[J].中华医学杂志,2006,86(31):2182-2187. 被引量:14
  • 2Van Venrooij WJ,van Beers JJ,Pruijn GJ. Anti-CCP antibodies:the past,the present and the future[J].Nat Rev Rheumatol,2011.391-398.
  • 3der Woude DV,Rantapaa-Dahlqvist S,Ioan-Facsinay A. Epitope spreading of the anti-citrullinated protein antibody response occurs before disease onset and is associated with the disease course of early arthritis[J].Annals of the Rheumatic Diseases,2010.1554-1561.
  • 4Kuhn KA,Kulik L,Tomooka B. Antibodies against citrullinated proteins enhance tissue injury in experimental autoimmune arthritis[J].Journal of Clinical Investigation,2006.961-973.doi:10.1172/JCI25422.
  • 5Turunen S,Koivula MK,Risteli L. Anticitrulline antibodies can be caused by homocitrulline-containing proteins in rabbits[J].Arthritis and Rheumatism,2010.3345-3352.doi:10.1002/art.27644.
  • 6Pruijn GJ,Wiik A,van Venrooij WJ. The use of citrullinated peptides and proteins for the diagnosis of rheumatoid arthritis[J].Arthritis Research & Therapy,2010.203.doi:10.1186/ar2903.
  • 7Ioan-Facsinay A,el-Bannoudi H,Scherer HU. Anti-cyclic citrullinated peptide antibodies are a collection of anti-citrullinated protein antibodies and contain overlapping and non-overlapping reactivities[J].Annals of the Rheumatic Diseases,2011.188-193.doi:10.1136/ard.2010.131102.
  • 8Raats JM,Wijnen EM,Pruijn GJ. Recombinant human monoclonal autoantibodies specific for citnlline-containingpeptides from phage display libraries derived from patients with rheumatoid arthritis[J].Journal of Rheumatology,2003.1696-1711.
  • 9Schellekens GA,Visser H,de Jong BA. The diagnostic properties of rheumatoid arthritis antibodies recognizing a cycliccitrullinated peptide[J].Arthritis and Rheumatism,2000.155-163.
  • 10Rooncy M,Condell D,Quinlan W. Analysis of the histologic variation of synovitis in rheumatoid arthritis[J].Arthritis and Rheumatism,1988.956-963.

引证文献2

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部